Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 18, 2021
Sterling Pharma Solutions, a global contract development and manufacturing organisation, announced the next phase of a multi-year investment strategy at its site in Dudley, UK. The £10m plan will see the building and commissioning of new process ...
read more
GHO Capital has acquired a majority stake in Sterling Pharma Solutions, a specialist in complex and difficult to manufacture APIs.
read more
Sterling Pharma Solutions has opened its new Material Science Centre (MSC), after announcing the investment last year.
read more
Tuesday, October 06, 2020
Sterling Pharma Solutions, has announced its acquisition of Alcami’s Germantown, Wisconsin facility in the US.
read more
Sterling Pharma Solutions is investing £6m into its pilot plant facility at its UK site to enhance its scale-up and small to midscale commercial API manufacturing capabilities.
read more
Sterling Pharma Solutions has announced the expansion of its pilot plant facility is now operational at its UK site following a £6million investment last year.
read more
Wednesday, December 16, 2020
Sterling Pharma has announced a new strategic partnership with ADC Bio, a UK based biotechnology company specializing in antibody drug conjugates.
read more
Stellar Biotechnologies announced that third-party trial results have demonstrated that the company's KLH manufacturing methods achieve robust viral clearance.
read more
Wednesday, December 09, 2020
Stelis BioSource has started the next phase of its continued investment program after having already invested well over $100m into its facilities in Bangalore, India.
read more
Wednesday, November 18, 2020
Stelis BioSource has started the next phase of its continued investment program.
read more
Thursday, December 27, 2018
The day before a planned Georgia General Assembly House study committee meeting, the Kratom Trade Association said it is reaching out to state lawmakers to directly resolve their concerns about kratom.
read more
Friday, February 22, 2019
Assessing and mitigating risks is at the heart of everything we do across our vast portfolio.
read more
We’ve long recognized that compounded drugs can serve an important role for patients whose medical needs cannot be met by an FDA-approved drug product.
read more
Wednesday, September 05, 2018
Over the past 25 years, globalization of drug manufacturing has prompted the FDA to change its regulatory landscape.
read more
Wednesday, February 14, 2018
Additional resources will help advance initiatives to support novel medical technology and public health priorities such as generic drug development, pharmacy outsourcing and novel domestic manufacturing capabilities.
read more